1 day Green stocks on red days Reddit

   X     

1 day Final Trade: TEVA, JNJ, TJX, BABA YouTube

   X     

2 days Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue? Zacks

   X     

4 days AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant Seeking Alpha

   X     

4 days Fast Money: CELH, SLV, EEM, JNJ YouTube

   X     

5 days Johnson & Johnson restarts limited U.S. release of VARIPULSE™ Investing.com

   X     

5 days J&J begins crucial battle over $10 billion baby powder settlement Investing.com

   X     

5 days Genmab: Positive 2025 Outlook, Johnson & Johnson’s Decision Coming Soon Seeking Alpha

   X     

5 days Johnson & Johnson: Rich History Of Excellence Poised To Endure Seeking Alpha

   X     

2 weeks Johnson & Johnson aims to sell Cerenovus for over $1 billion – Financial Times Investing.com

   X     

3 weeks DCLA’s Sarat Sethi on his top stock picks: JNJ, WDAY, TMO YouTube

   X     

3 weeks J&J Snack Foods Corp. (JJSF) Q1 2025 Earnings Call Transcript Seeking Alpha

   X     

3 weeks CHMP Gives Nod to Expanded Use of J&J’s Rybrevant & AZN’s Imfinzi Zacks

   X     

3 weeks J&J Snack Foods’ Q1 Earnings Lag Estimates, Sales Grow 4.1% Y/Y Zacks

   X     

3 weeks J&J Snack Foods (JJSF) Reports Q1 Earnings: What Key Metrics Have to Say Zacks

   X     

3 weeks J&J Snack Foods (JJSF) Lags Q1 Earnings Estimates Zacks

   X     

3 weeks The Zacks Analyst Blog Highlights NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern Zacks

   X     

3 weeks Is Johnson & Johnson Stock a Buy? Yahoo Finance

   X     

3 weeks Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock’s Fortunes Around? Yahoo Finance

   X     

3 weeks Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock? Yahoo Finance

   X     

3 weeks Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile Zacks

   X     

3 weeks US government could seek over $1 billion from J&J for cancer treatment costs Investing.com

   X     

3 weeks Why Johnson & Johnson’s Strong Buy Rating Is Justified (Rating Upgrade) Seeking Alpha

   X     

4 weeks Here’s Why Johnson & Johnson (JNJ) is a Strong Value Stock Zacks

   X     

4 weeks How to Play J&J Stock After Q4 Beat & Soft 2025 Sales Guidance Zacks

   X     

4 weeks Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock Zacks

   X     

4 weeks Pharma Stock Roundup: JNJ’s Q4 Earnings, FDA Nod to AZN, Daiichi Drug Zacks

   X     

4 weeks Market Digest: FDX, JNJ, MKC, RF, KMI, GEV Yahoo Finance

   X     

1 month Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Zacks

   X     

1 month Zacks Earnings Trends Highlights: Netflix and Johnson & Johnson Zacks

   X     

1 month 3-Stock Lunch: Netflix, Johnson & Johnson, Travelers YouTube

   X     

1 month Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings Fast Company

   X     

1 month Johnson & Johnson Dips On Q4 Earnings: Here’s What The Market Isn’t Seeing Seeking Alpha

   X     

1 month Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

1 month Downside risk from talc lawsuit, Stelara generic competition is ‘manageable’: JNJ CFO Joe Wolk Yahoo Finance

   X     

1 month J&J’s Depression Drug Spravato Gets FDA Nod for Monotherapy Use Zacks

   X     

1 month J&J’s Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance Zacks

   X     

1 month Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings Yahoo Finance

   X     

1 month Pre-Markets Keep Optimistic, Earnings Beats for JNJ, PG, ALLY & More Zacks

   X     

1 month J&J Skids After Dow Giant Beat Earnings Views, But ‘Prudent’ Guidance Disappoints Investor's Business Daily

   X     

1 month Johnson & Johnson 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha

   X     

1 month Compared to Estimates, Johnson & Johnson (JNJ) Q4 Earnings: A Look at Key Metrics Zacks

   X     

1 month Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth Yahoo Finance

   X     

1 month Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook Yahoo Finance

   X     

1 month Netflix, Oracle, Travelers and Procter & Gamble rise premarket; J&J falls Investing.com

   X     

1 month J&J CFO Joe Wolk: Anticipating 3% operational growth in 2025 despite ‘significant’ headwinds YouTube

   X     

1 month Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates Zacks

   X     

1 month Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance MarketWatch

   X     

1 month J&J tops earnings estimates amid strong demand for cancer treatments Investing.com

   X     

1 month J&J Reports Strong Revenue and Profit but Faces Challenges in 2025 Yahoo Finance

   X